These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6822217)

  • 1. Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas.
    Ghatei MA; Uttenthal LO; Bryant MG; Christofides ND; Moody AJ; Bloom SR
    Endocrinology; 1983 Mar; 112(3):917-23. PubMed ID: 6822217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat.
    Kervran A; Blache P; Bataille D
    Endocrinology; 1987 Aug; 121(2):704-13. PubMed ID: 3595539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular forms of human enteroglucagon in tissue and plasma: plasma responses to nutrient stimuli in health and in disorders of the upper gastrointestinal tract.
    Ghatei MA; Uttenthal LO; Christofides ND; Bryant MG; Bloom SR
    J Clin Endocrinol Metab; 1983 Sep; 57(3):488-95. PubMed ID: 6874888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an oxyntomodulin/glicentin C-terminal radioimmunoassay using a "thiol-maleoyl" coupling method for preparing the immunogen.
    Blache P; Kervran A; Martinez J; Bataille D
    Anal Biochem; 1988 Aug; 173(1):151-9. PubMed ID: 3189794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxyntomodulin and glicentin: brain-gut peptides in the rat.
    Blache P; Kervran A; Bataille D
    Endocrinology; 1988 Dec; 123(6):2782-7. PubMed ID: 3197645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut.
    Böttcher G; Sjölund K; Ekblad E; Håkanson R; Schwartz TW; Sundler F
    Regul Pept; 1984 Jul; 8(4):261-6. PubMed ID: 6548568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry.
    Varndell IM; Bishop AE; Sikri KL; Uttenthal LO; Bloom SR; Polak JM
    J Histochem Cytochem; 1985 Oct; 33(10):1080-6. PubMed ID: 3900195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of glicentin to proglucagon and glucagon in the porcine pancreas.
    Moody AJ; Holst JJ; Thim L; Jensen SL
    Nature; 1981 Feb; 289(5797):514-6. PubMed ID: 7007887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and chemical characterization of glicentin C-terminal hexapeptide in porcine pancreas.
    Yanaihara C; Matsumoto T; Hong YM; Yanaihara N
    FEBS Lett; 1985 Sep; 189(1):50-6. PubMed ID: 4029398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Enigmatic N-Terminal Domain of Proglucagon; A Historical Perspective.
    Conlon JM
    Front Endocrinol (Lausanne); 2021; 12():683089. PubMed ID: 34177808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The primary structure of porcine glicentin (proglucagon).
    Thim L; Moody AJ
    Regul Pept; 1981 May; 2(2):139-50. PubMed ID: 6894800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glicentin is present in the pig pancreas.
    Sheikh SP; Baldissera FG; Karlsen FO; Holst JJ
    FEBS Lett; 1985 Jan; 179(1):1-6. PubMed ID: 3965295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactive glucagons purified from dog pancreas, stomach and ileum.
    Shinomura Y; Eng J; Yalow RS
    Regul Pept; 1988 Dec; 23(3):299-308. PubMed ID: 3238052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glicentin and gastric inhibitory polypeptide immunoreactivity in endocrine cells of the gut and pancreas.
    Larsson LI; Moody AJ
    J Histochem Cytochem; 1980 Sep; 28(9):925-33. PubMed ID: 6997368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric inhibitory peptide-like immunoreactivity in glucagon and glicentin cells: properties and origin. An immunocytochemical study using several antisera.
    Sjölund K; Ekelund M; Håkanson R; Moody AJ; Sundler F
    J Histochem Cytochem; 1983 Jun; 31(6):811-7. PubMed ID: 6188783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas.
    Uttenthal LO; Ghiglione M; George SK; Bishop AE; Polak JM; Bloom SR
    J Clin Endocrinol Metab; 1985 Sep; 61(3):472-9. PubMed ID: 2991321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glicentin-related peptides on glucagon secretion in anaesthetized dogs.
    Ohneda A; Kobayashi T; Nihei J
    Diabetologia; 1986 Jun; 29(6):397-401. PubMed ID: 3527839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon and the gut.
    Buchanan KD; Zandomeneghi R; Murphy RF; Teale JD
    Gut; 1971 Oct; 12(10):861. PubMed ID: 5123283
    [No Abstract]   [Full Text] [Related]  

  • 19. Pancreatic and intestinal processing of proglucagon in man.
    Orskov C; Holst JJ; Poulsen SS; Kirkegaard P
    Diabetologia; 1987 Nov; 30(11):874-81. PubMed ID: 3446554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin.
    Holst JJ
    Biochem J; 1982 Dec; 207(3):381-8. PubMed ID: 7165698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.